Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, David M Asmuth, Barry Peters, Adriano Lazzarin, Felipe Garcia, Kim Ellefsen, Daniel Podzamczer, Jan van Lunzen, Keikawus Arastéh, Dirk Schürmann, Bonaventura Clotet, W David Hardy, Ronald Mitsuyasu, Graeme Moyle, Andreas Plettenberg, Martin Fisher, Gerd Fätkenheuer, Margaret Fischl, Babafemi Taiwo, Ingebjørg Baksaas, Darren Jolliffe, Stefan Persson, Øyvind Jelmert, Arnt-Ove Hovden, Maja A Sommerfelt, Vidar Wendel-Hansen, Birger Sørensen

Open source

DOI: 10.1016/s1473-3099(13)70343-8
Published: 2014-04
Container: The Lancet Infectious Diseases
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-13-70343-8,
  title = {Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial},
  author = {Richard B Pollard and Jürgen K Rockstroh and Giuseppe Pantaleo and David M Asmuth and Barry Peters and Adriano Lazzarin and Felipe Garcia and Kim Ellefsen and Daniel Podzamczer and Jan van Lunzen and Keikawus Arastéh and Dirk Schürmann and Bonaventura Clotet and W David Hardy and Ronald Mitsuyasu and Graeme Moyle and Andreas Plettenberg and Martin Fisher and Gerd Fätkenheuer and Margaret Fischl and Babafemi Taiwo and Ingebjørg Baksaas and Darren Jolliffe and Stefan Persson and Øyvind Jelmert and Arnt-Ove Hovden and Maja A Sommerfelt and Vidar Wendel-Hansen and Birger Sørensen},
  year = {2014},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(13)70343-8},
  url = {https://doi.org/10.1016/s1473-3099(13)70343-8}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
AU  - Richard B Pollard
AU  - Jürgen K Rockstroh
AU  - Giuseppe Pantaleo
AU  - David M Asmuth
AU  - Barry Peters
AU  - Adriano Lazzarin
AU  - Felipe Garcia
AU  - Kim Ellefsen
AU  - Daniel Podzamczer
AU  - Jan van Lunzen
AU  - Keikawus Arastéh
AU  - Dirk Schürmann
AU  - Bonaventura Clotet
AU  - W David Hardy
AU  - Ronald Mitsuyasu
AU  - Graeme Moyle
AU  - Andreas Plettenberg
AU  - Martin Fisher
AU  - Gerd Fätkenheuer
AU  - Margaret Fischl
AU  - Babafemi Taiwo
AU  - Ingebjørg Baksaas
AU  - Darren Jolliffe
AU  - Stefan Persson
AU  - Øyvind Jelmert
AU  - Arnt-Ove Hovden
AU  - Maja A Sommerfelt
AU  - Vidar Wendel-Hansen
AU  - Birger Sørensen
PY  - 2014
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(13)70343-8
UR  - https://doi.org/10.1016/s1473-3099(13)70343-8
ER  -

APA

Pollard, R. B., Rockstroh, J. K., Pantaleo, G., Asmuth, D. M., Peters, B., Lazzarin, A., Garcia, F., Ellefsen, K., Podzamczer, D., Lunzen, J. V., Arastéh, K., Schürmann, D., Clotet, B., Hardy, W. D., Mitsuyasu, R., Moyle, G., Plettenberg, A., Fisher, M., Fätkenheuer, G., Fischl, M., Taiwo, B., Baksaas, I., Jolliffe, D., Persson, S., Jelmert, Ø., Hovden, A., Sommerfelt, M. A., Wendel-Hansen, V., & Sørensen, B. (2014). Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(13)70343-8

Source records

crossref · retrieved 2026-09-27T00:04:45.893Z